Trial | NCT00512785  Report issue

Title

Long-term Safety and Efficacy of Imidafenacin in Patients With Overactive Bladder
An Open-label Study to Evaluate the Long-term Safety and Efficacy of Imidafenacin in Patients With Overactive Bladder

  • Phase

    Phase 3

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    imidafenacin ...

  • Study Participants

    435
The purpose of this study is to evaluate the long-term safety and efficacy of imidafenacin.
Study Started
Aug 31
2007
Primary Completion
May 31
2009
Last Update
Jun 13
2012
Estimate

Drug imidafenacin, KRP-197/ONO-8025

0.1 mg BID for 52 weeks

Drug imidafenacin, KRP-197/ONO-8025

0.1 mg BID for 12 weeks and 0.2 mg BID for 52 weeks

E1 Experimental

E2 Experimental

Criteria 

Inclusion Criteria:

Men and Woman equal or > 20 years old
Patients with urgency, urinary frequency and urgency incontinence

Exclusion Criteria:

Patients with genuine stress incontinence
Patients suffering from complications such as bladder tumor, urinary tract stone and symptomatic urinary tract infection
Patients suffering from complications contraindicating the use of antimuscarinic medication
Patients with polyuria
No Results Posted